Comparison Between Preoperative Administration of Methylprednisolone With its Administration Before and During Congenital Heart Surgery on Serum Levels of IL-6 And IL-10

AUTHORS

Mohammad Abbasi Tashnizi 1 , Ghasem Soltani 2 , Ali Asghar Moeinipour 1 , Hossein Ayatollahi 3 , Amir Saber Tanha 2 , Lida Jarahi 4 , Alireza Sepehri Shamloo 1

1 Department of Cardiac Surgery, Imam Reza Hospital, Mashhad University of Medical

2 Departments of Anesthesiology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran

3 Department of Anatomical and Clinical Pathology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran

4 Departments of Community Medicine, Mashad University of Medical Sciences, Mashad, IR Iran

Warning: No corresponding author defined!

How to Cite: Abbasi Tashnizi M, Soltani G, Moeinipour A A, Ayatollahi H, Tanha A S, et al. Comparison Between Preoperative Administration of Methylprednisolone With its Administration Before and During Congenital Heart Surgery on Serum Levels of IL-6 And IL-10, Iran Red Crescent Med J. Online ahead of Print ; 15(2):147-51. doi: 10.5812/ircmj.8039.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 15 (2); 147-51
Published Online: February 4, 2013
Article Type: Research Article
Received: September 2, 2012
Accepted: January 7, 2013
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Steroid administration during cardiopulmonary bypass is considered to improve cardiopulmonary function by modulating inflammations caused by bypass.

Objectives: This study was performed to compare effectiveness of preoperative and intraoperative methylprednisolone (MP) to preoperative methylprednisolone alone in post bypass inflammatory (IL-6) and anti-inflammatory (IL-10) factors.

Patients and Methods: Fifty pediatric patients undergoing cardiopulmonary bypass surgery from August 2011 to 2012 in the cardiac surgery department of Imam Reza Hospital, the major center for CPB, in Mashhad, Iran were randomly assigned to receive preoperative and intraoperative MP (30 mg/kg, 4 hours before bypass and in bypass prime, number 25) or preoperative MP only (30 mg/kg, number 25). Before and after bypass, four and 24 hours after bypass, serum IL-6 and IL-10 were measured by ELISA.

Results: In both groups, no significant difference with variation of expression for IL-6 (inflammatory factor) and IL-10 (anti-inflammatory factor) in different times after bypass was observed.

Conclusions: No significant difference in reducing post bypass inflammation between preoperative steroid treatment and combined preoperative and intraoperative steroid administration reported and they had the same effects.

Keywords

Cardiopulmonary Bypass Heart Defects, Congenital Interleukins Inflammation

© 2013, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: